A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

Clinical trial NCT05932862 · RECRUITING

Trial details

NCT number: NCT05932862
Sponsor: Exelixis
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-04-03
Primary completion: 2029-01-03
Enrollment: 429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.